 | Up a level |
Jump to: 2022
Number of items: 1.
2022
Henes, J., Saur, S., Kofler, D. M., Kedor, C., Meisner, C., Krusche, M., Koetter, I., Xenitidis, T., Schulze-Koops, H. and Feist, E. (2022). TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER - DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY. Ann. Rheum. Dis., 81. S. 30 - 32. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060